Works matching IS 13866346 AND DT 2024 AND VI 54 AND IP 10


Results: 10
    1
    2
    3
    4
    5
    6
    7

    Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease.

    Published in:
    Hepatology Research, 2024, v. 54, n. 10, p. 912, doi. 10.1111/hepr.14039
    By:
    • Nouso, Kazuhiro;
    • Kawanaka, Miwa;
    • Fujii, Hideki;
    • Kariyama, Kazuya;
    • Toyoda, Hidenori;
    • Iwaki, Michihiro;
    • Hayashi, Hideki;
    • Oeda, Satoshi;
    • Hyogo, Hideyuki;
    • Morishita, Asahiro;
    • Munekage, Kensuke;
    • Kawata, Kazuhito;
    • Tsutsumi, Tsubasa;
    • Sawada, Koji;
    • Maeshiro, Tatsuji;
    • Tobita, Hiroshi;
    • Yoshida, Yuichi;
    • Naito, Masafumi;
    • Araki, Asuka;
    • Arakaki, Shingo
    Publication type:
    Article
    8

    Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.

    Published in:
    Hepatology Research, 2024, v. 54, n. 10, p. 877, doi. 10.1111/hepr.14036
    By:
    • Yamada, Shunsuke;
    • Uchida, Yoshihito;
    • Kouyama, Jun‐Ichi;
    • Naiki, Kayoko;
    • Tsuji, Shohei;
    • Uemura, Hayato;
    • Sugawara, Kayoko;
    • Nakayama, Nobuaki;
    • Imai, Yukinori;
    • Tomiya, Tomoaki;
    • Mizuno, Suguru;
    • Mochida, Satoshi
    Publication type:
    Article
    9
    10

    Issue Information.

    Published in:
    Hepatology Research, 2024, v. 54, n. 10, p. 869, doi. 10.1111/hepr.13922
    Publication type:
    Article